Valuation
Startup Valuation Methods: Which Approach Fits Each Stage?
A practical guide to DCF, comparables, venture capital and early-stage methods—and their limitations.
Match the method to the evidence
A valuation method is only as useful as the evidence available to support it. A pre-revenue business cannot be valued with the same confidence as a mature company with stable margins and predictable cash flow.
For very early companies, scorecard, risk-factor or milestone-based approaches can organize judgement, but they do not create objective value. They are best treated as negotiation frameworks and cross-checks.
- Pre-revenue: milestone, scorecard and risk-based frameworks
- Early revenue: venture capital method and relevant transaction evidence
- Scaling business: revenue or EBITDA comparables with forward economics
- Mature cash-generative business: DCF and trading comparables
Use more than one lens
Comparable-company analysis can anchor market expectations, but the selected peers, growth differences and liquidity adjustments often matter more than the median multiple. Transaction comparables may be closer to an investor decision, yet deal terms and private information are rarely fully visible.
A DCF forces discipline around unit economics, reinvestment and long-term margins. For an early startup, however, small changes in terminal assumptions can dominate the result. It is usually more useful as a scenario framework than as a single precise answer.
Value is not the whole deal
The headline pre-money valuation does not capture liquidation preferences, anti-dilution terms, option-pool treatment, control rights or future funding risk. Two offers at the same valuation can produce very different founder and investor outcomes.
A defensible conclusion is therefore a valuation range, a clear explanation of the methods and a financing structure that aligns capital, milestones and risk.